Adrien R.
- Country
- France
- Department
- Réanimation – Soins continus
Research Overview
- Phase III Randomized Controlled Trial of Intravenous Dexamethasone for Severe Influenza‑Induced Acute Hypoxemic Respiratory Failure
- A multicentre, double-blind, randomized controlled trial of inhaled amikacin versus placebo in critically ill patients with ventilator-associated tracheobronchitis (AMIVAT)
Data & Insights
Has run more than one trial at 7 of 49 partner sites.
Specializations
Critical Care & Respiratory Medicine
Focus on severe respiratory infections and acute respiratory failure in the intensive care setting.
- severe community-acquired bacterial pneumonia
- ventilator-associated tracheobronchitis
- hypoxemic acute respiratory failure
- sepsis
- high-flow nasal oxygen therapy weaning
Emphasis on interventions that lower mortality and dependence on organ‑support technologies.
Breast Oncology – Hormone Receptor Positive & HER2‑negative
Investigates endocrine and targeted approaches for ER‑positive, HER2‑negative breast cancer across curative and metastatic stages.
- adjuvant endocrine therapy duration
- CDK4/6 inhibitor combinations
- PARP inhibitor plus immunotherapy strategies
- ctDNA‑guided treatment de‑escalation
- high‑risk HR‑positive/HER2‑negative disease
Focus on minimizing recurrence while preserving quality of life.
Breast Oncology – HER2‑positive & Triple‑Negative
Addresses therapeutic strategies for HER2‑positive and early triple‑negative breast cancer.
- anti‑HER2 maintenance after two years
- de‑escalation based on ctDNA negativity
- neoadjuvant pembrolizumab in triple‑negative disease
- adjuvant trastuzumab‑deruxtecan studies
- antibody‑drug conjugate integration
Integration of novel antibody‑drug conjugates and immunotherapy modalities.
Hematologic Malignancies
Engages in trials targeting multiple myeloma and related plasma‑cell disorders.
- daratumumab‑lenalidomide‑dexamethasone fixed‑duration regimens
- subcutaneous daratumumab administration
- elranatamab‑lenalidomide consolidation
- minimal residual disease‑guided transplant strategies
- frail patient‑focused myeloma therapies
Aims to deepen response and sustain remission in diverse patient populations.
Pediatric Metabolism & Neurovascular
Covers metabolic optimization in children and prevention of recurrent cerebrovascular events.
- monthly versus daily vitamin D bolus
- milvexian for ischemic stroke risk reduction
- high‑risk transient ischemic attack management
- obesity‑related vitamin D deficiency correction
- long‑term vascular health strategies
Targets sustained vascular health and metabolic balance in pediatric cohorts.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.